Rapid succession of peripheral blood progenitor cell mobilization cycles in patients with chronic heart failure: Effects on the hematopoietic system

Transfusion

Volumn 46, Issue 8, 2006, Pages 1424-1431

  Hüttmann, Andreas ^a   Gutersohn, Achim ^a   Noppeney, Richard ^a   Neumann, Till ^a   Erbel, Raimund ^a   Dührsen, Ulrich ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BASOPHIL; CD34 SELECTION; CLINICAL ARTICLE; EOSINOPHIL; ERYTHROCYTE COUNT; HEART FAILURE; HEMATOPOIETIC SYSTEM; HUMAN; LEUKOCYTE COUNT; MALE; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; THROMBOCYTE COUNT; THROMBOCYTOSIS; THROMBOSIS;

AGED; ANTIGENS, CD34; CHRONIC DISEASE; COHORT STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART FAILURE, CONGESTIVE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33746369724     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00912.x     Document Type: Article

References (38)

1. Hüttmann A, Li CL, Dührsen U. Bone marrow-derived stem cells and "plasticity." Ann Hematol 2003;82:599-604.
2. Körbling M, Estrov Z. Adult stem cells for tissue repair - a new therapeutic concept ? N Engl J Med 2003;349:570-82.
3. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
4. Stamm C, Westphal B, Kleine HD, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361:45-6.
5. Tse HF, Kwong YL, Chan JK, et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003;361:47-9.
6. Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294-302.
7. McCarthy DM, Goldman JM. Transfusion of circulating stem cells. Crit Rev Clin Lab Sci 1984;20:1-24.
8. Dührsen U, Villeval JL, Boyd J, et al. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988;72:2074-81.
9. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood 1997;89:2233-58.
10. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001;98:10344-9.
11. Weite K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G. Filgrastim (r-metHuG-CSF): the first 10 years. Blood 1996;88:1907-29.
12. Matsunaga T, Sakamaki S, Kohgo Y, et al. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 1993;11:103-8.
13. Dührsen U, Sheridan WP. G-CSF: role in bone marrow and peripheral blood stem cell transplantation. In: Mertelsmann R, Herrmann F, editors. Hematopoietic growth factors in clinical applications. New York: Marcel Dekker Inc.; 1994. p. 241-56.
14. Stroncek DF, Clay ME, Petzoldt ML, et al. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996;36:601-10.
15. Hüttmann A, Dührsen U, Stypmann J, et al. Granulocyte colony-stimulating factor induced blood stem cell mobilisation in patients with chronic heart failure: feasibility, safety and effects on exercise tolerance and cardiac function. Bas Res Cardiol 2006;101:78-86.
16. Bronchud MH, Scarffe JH, Thatcher N, et al. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 1987;56:809-13.
17. Morstyn G, Campbell L, Souza LM, et al. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988;1:667-72.
18. Gabrilove JL, Jakubowski A, Fain K, et al. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 1988;82:1454-61.
19. Lindemann A, Herrmann F, Oster W, et al. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 1989;74:2644-51.
20. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81:1883-8.
21. Stroncek DF, Yau YY, Oblitas J, Leitman SF. Administration of G-CSF plus dexamethasone produces greater granulocyte concentrate yields while causing no more donor toxicity than G-CSF alone. Transfusion 2001;41:1037-44.
22. Körbling M, Huh YO, Durett A, et al. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995;86:2842-8.
23. Stroncek DF, Clay ME, Smith J, et al. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors. Transfusion 1996;36:596-600.
24. Anderlini P, Przepiorka D, Seong D, et al. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion 1996;36:590-5.
25. Metcalf D, Nicola NA. The hemopoietic colony-stimulating factors. Cambridge: Cambridge University Press; 1995.
26. Molineux G, Dexter T. Biology of G-CSF. In: Morstyn G, Dexter TM, Foote M, editors. Filgrastim (R-MetHuG-CSF) in clinical practice. 2nd ed. New York: Marcel Dekker Inc.; 1998. p. 1-39.
27. Lapidot T, Petit I. Current understanding of stem cell mobilization, the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002;30:973-81.
28. Dale DC, Bonilla MA, Davis MW, et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993;81:2496-502.
29. Tichelli A, Passweg J, Hoffmann T, et al. Repeated peripheral stem cell mobilization in healthy donors: time-dependent changes in mobilization efficiency. Br J Haematol 1999;106:152-8.
30. Anderlini P, Körbling M. The use of mobilized peripheral blood stem cells from normal donors for allografting. Stem Cells 1997;15:9-17.
31. Holm M, Hokland P. Not all healthy donors mobilize hematopoietic progenitor cells sufficiently after G-CSF administration to allow for subsequent CD34 purification of the leukapheresis product. J Hematother 1998;7:111-3.
32. Wang Y, Tägil K, Ripa RS, et al. Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease. Int J Cardiol 2005;100:477-83.
33. Basara N, Schmetzer B, Blau IW, et al. Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study. Bone Marrow Transplant 2000;25:371-6.
34. De la Rubia J, Arbona C, de Arriba F, et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion 2002;42:4-9.
35. Shimizu N, Asai T, Hashimoto S, et al. Mobilization factors of peripheral blood stem cells in healthy donors. Ther Apher 2002;6:413-8.
36. Auer J, Berent R, Eber B. Amiodarone in the prevention and treatment of arrhythmia. Curr Opin Invest Drugs 2002;3:1037-44.
37. Hosaka F, Shiga T, Sakomura Y, et al. Amiodarone distribution in human tissues after long-term therapy: a case of arrhythmogenic right ventricular cardiomyopathy. Heart Vessels 2002:16:154-6.
38. Yasuda SU, Sausville EA, Hutchins JB, Kennedy T, Woosley RL. Amiodarone-induced lymphocyte toxicity and mitochondrial function. J Cardiovasc Pharmacol 1996;28:94-100.